Application 211427
- Type
- ANDA
- Sponsor
- MACLEODS PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | TABLET, EXTENDED RELEASE;ORAL | EQ 50MG BASE | No | No |
| 002 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | TABLET, EXTENDED RELEASE;ORAL | EQ 100MG BASE | No | No |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A211427-001 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | | 2025-01-15 |
| A211427-002 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | | 2025-01-15 |
Therapeutic equivalence codes#